Probiotics Against Pathogenic Bacteria and Cancer

This review focuses on the role of probiotics as alternative prevention and treatment of cancer. In this regard, we discuss the alternative cancer biotherapeutic drugs including live or dead probiotics and their metabolites, such as short chain fatty acids, inhibitory compounds of protein, polysaccharide, nucleic acid and ferrichrome in vitro, in vivo and clinical studies. We also summarize the available data on the relationship between the development of cervical, breast and colorectal cancers, and microbiome, as well as data about the potential of probiotics as an alternative approach to cancer prevention and treatment. Material and Methods. A literature search was conducted using the Pubmed and eLibrary databases. Of 140 publications, the review included 57 studies.